A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in de novo Kidney Transplant Recipients

  • Waid, Thomas (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date4/23/08 → 8/31/11